Translation of Omic Data into Personalised Oncology Tools The Challenge and the Reward William Gallagher, University College Dublin, speaking at Diagnostics & Biomarkers 2015.
Plasma Vitronectin Predicts Response to Fluoropyrimidine-oxaliplatin (FOLFOX) Chemotherapy in Metastatic Colorectal Cancer Sarah Hayes, University of Sydney, speaking at Diagnostics & Biomarkers 2015.
Drug Sensitivity and Resistance Testing Platform for Personalized Medicine at the Institute for Molecular Medicine Finland (FIMM) Jani Saarela, Institute for Molecular Medicine, speaking at Screening Europe 2015
Oncology Biomarker Testing Current US Practice Baseline and Emerging Trends Julia Trosman, Center for Business Models in Healthcare, speaking at Diagnostics & Biomarkers 2015.
Novel Chip-based Extraction of miRNA Gregory Dame, University of Freiburg, speaking at Point of Care Diagnostics 2015
Imaging Biomarkers - Future or Reality Edwin van Beek, University of Edinburgh, speaking at Diagnostics & Biomarkers 2015.
Discovery of Potent and Selective Inhibitors of Monopolar Spindle 1 (MPS1) Kinase Rob van Montfort, The Institute of Cancer Research, speaking at Discovery Chemistry Congress 2015.
Fit-for-Purpose Biomarker Assay Validation - From Research Tool to Diagnostic Test Jeff Cummings, Cancer Research UK, speaking at Diagnostics & Biomarkers 2015.
Biomarkers to Predict Aggressive Prostate Cancer Claire Morgan, Swansea University, speaking at Diagnostics & Biomarkers 2015.
Modifying Cell Lines for Target Discovery and Validation In this 30-minute seminar, we will discuss the process of genome editing, address factors affecting the design of a genome editing project, and explore the application of modified cell lines for target discovery and validation.